Senex Biotechnology: Funding, Investors & Team (Oct 2026)
Senex Biotechnology, Inc. is focused on researching and creating therapeutic drugs for cancer, viral infections, and age-related illnesses. The company develops SNX2 compounds for viral and age-related diseases, as well as supplementary treatments for cancer drugs. They also produce SNX9 inhibitors for cancer treatment. Senex Biotechnology provides treatments for various diseases associated with aging, including Alzheimer's disease, kidney disease, heart disease, and arthritis. Established in 2002, the company is located in Columbia, South Carolina.
Senex Biotechnology has raised $400k across 1 funding round on record, the most recent an undisclosed round of $400k announced in Jan 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Senex Biotechnology Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Senex Biotechnology Funding Rounds
Senex Biotechnology Founders and Leadership Team
No contact details are on record for this team yet.
Senex Biotechnology Funding Compared to Other Biotechnology Startups
Senex Biotechnology's latest round of $400k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Senex Biotechnology in Biotechnology and Columbia
Companies Similar to Senex Biotechnology
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Senex Biotechnology Funding FAQs
What does Senex Biotechnology do?
Senex Biotechnology, Inc. is focused on researching and creating therapeutic drugs for cancer, viral infections, and age-related illnesses. The company develops SNX2 compounds for viral and age-related diseases, as well as supplementary treatments for cancer drugs. They also produce SNX9 inhibitors for cancer treatment. Senex Biotechnology provides treatments for various diseases associated with aging, including Alzheimer's disease, kidney disease, heart disease, and arthritis. Established in 2002, the company is located in Columbia, South Carolina.
How much funding has Senex Biotechnology raised?
Senex Biotechnology has raised $400k across 1 round on record. The most recent is an undisclosed round of $400k announced in Jan 2025.
When did Senex Biotechnology last raise funding?
Senex Biotechnology's most recent funding round on record is an undisclosed round of $400k, announced in Jan 2025.
Who founded Senex Biotechnology?
FundedIQ lists Igor Roninson (Founder) at Senex Biotechnology.
Where is Senex Biotechnology headquartered?
Senex Biotechnology is based in Columbia, South Carolina, United States.
How many employees does Senex Biotechnology have?
Senex Biotechnology is in the 11-50 employee band.
How does Senex Biotechnology's funding compare to other Biotechnology startups?
Senex Biotechnology's latest round of $400k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Senex Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Senex Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.